"We believe that Amgen is ideally suited to realize the full potential of Onyx's portfolio and pipeline for the benefit of physicians and patients," said Amgen CEO Robert Bradway in a statement.
http://www.thestreet.com/story/12018459/1/the-deal-amgen-soars-on-104b-onyx-deal.html?cm_ven=RSSFeed
http://www.thestreet.com/story/12018459/1/the-deal-amgen-soars-on-104b-onyx-deal.html?cm_ven=RSSFeed
No comments:
Post a Comment